Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.714138
Abstract: Non-responsiveness to anti-TNF-α therapies presents relevant rates in inflammatory bowel disease patients, presenting the need to find biomarkers involved in therapeutic efficacy. Herein, we demonstrate that higher levels of colonic formyl peptide receptor 1 and…
read more here.
Keywords:
peptide receptors;
receptors annexin;
disease;
formyl peptide ... See more keywords